In focus · trending topic

silicon valley biotechnology

3 stories · following the connections

Ascendis Pharma A/S Announces Third Quarter 2017 Financial Results Conference Call on November 16

By Nasdaq OMXNov 2, 2017, 10:45 PM UTC

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

By Nasdaq OMXSep 27, 2017, 4:16 AM UTC

Ascendis Pharma A/S Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH

By Nasdaq OMXSep 26, 2017, 12:01 PM UTC